DHX33 inhibitors induced transcriptional changes for a subset of genes in cancer cells

Xingshun Wang1, Yichu Fu2, Xiyu Tang3

  • 1School of Health and Nursing, Yunnan Open University, Kunming, 650500, Yunnan, China.

Scientific Reports
|June 4, 2026
PubMed

Insights

Small molecule inhibitors targeting RNA helicase DHX33 (RHA) activity mimic gene expression changes seen with DHX33 knockdown. This suggests DHX33

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Drug Discovery

Background:

  • RNA helicase DHX33 (RHA) is implicated in cancer development.
  • The role of DHX33's helicase activity in its cellular functions is not fully understood.

Purpose of the Study:

  • To investigate whether DHX33's helicase activity is essential for its role in regulating gene transcription in cancer cells.
  • To compare the effects of DHX33 helicase inhibition with DHX33 knockdown on gene expression.

Main Methods:

  • Utilized small molecule inhibitors (BCD38 and KY386) targeting DHX33 helicase activity.
  • Performed gene transcriptional profiling upon inhibitor treatment and compared with DHX33 knockdown data.
  • Evaluated effects in human cancer cells in vitro and in vivo.

Main Results:

  • DHX33 inhibitors induced transcriptional changes in a subset of genes, recapitulating DHX33 knockdown effects.
  • Inhibitors selectively downregulated genes associated with cancer progression.
  • Observed some discrepancies between inhibitor effects and knockdown, suggesting nuanced regulation.

Conclusions:

  • Targeting DHX33 helicase activity with small molecules induces gene expression changes mimicking DHX33 knockdown.
  • The cellular functions of DHX33 are dependent on its helicase activity.
  • Small molecule inhibitors offer a viable strategy to study and potentially target DHX33 in cancer.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...